tiprankstipranks
Trending News
More News >
BG Medicine Inc (BGMD)
:BGMD
US Market
Advertisement

BG Medicine (BGMD) Price & Analysis

Compare
17 Followers

BGMD Stock Chart & Stats

$0.02
$0.00(0.00%)
At close: 4:00 PM EST
$0.02
$0.00(0.00%)

BGMD FAQ

What was BG Medicine Inc’s price range in the past 12 months?
Currently, no data Available
What is BG Medicine Inc’s market cap?
Currently, no data Available
When is BG Medicine Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BG Medicine Inc’s earnings last quarter?
Currently, no data Available
Is BG Medicine Inc overvalued?
According to Wall Street analysts BG Medicine Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does BG Medicine Inc pay dividends?
    BG Medicine Inc does not currently pay dividends.
    What is BG Medicine Inc’s EPS estimate?
    BG Medicine Inc’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does BG Medicine Inc have?
    Currently, no data Available
    What happened to BG Medicine Inc’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of BG Medicine Inc?
    Currently, no hedge funds are holding shares in BGMD

    Company Description

    BG Medicine Inc

    BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.
    Similar Stocks
    Company
    Price & Change
    Follow
    Harvard Bioscience
    Milestone Scientific
    Microbot Medical
    GlucoTrack
    Femasys
    Popular Stocks
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis